Online Scam, NJ, USA
3 weeks ago •reported by user-vqqn8125
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
1 year ago •source www.fda.gov
Recall notice
United States
Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules. USP 75 mg and 150 mg to the consumer/user level due to the presence of a nitrosamine. N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level. The product lots were distributed nationwide to wholesalers, Distributors and Retailers (dispensers) in the United States from June 2022 to October 2022. To date, Ascend Laboratories LLC., has not received any reports of adverse events related to this recall.3 weeks ago •reported by user-vqqn8125
1 week ago •reported by user-gktzz333
2 days ago •reported by user-gxnrf514
2 weeks ago •reported by user-vcjnp739
3 weeks ago •reported by user-dbjqn471
4 weeks ago •reported by user-txfph166
1 week ago •reported by user-npydn393
2 weeks ago •reported by user-jbndt873
4 days ago •reported by user-krcc5469
2 weeks ago •reported by user-bgktg429
Search